B. Bandstra

494 total citations
7 papers, 363 citations indexed

About

B. Bandstra is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Epidemiology. According to data from OpenAlex, B. Bandstra has authored 7 papers receiving a total of 363 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 4 papers in Oncology and 2 papers in Epidemiology. Recurrent topics in B. Bandstra's work include Lung Cancer Treatments and Mutations (5 papers), Colorectal Cancer Treatments and Studies (2 papers) and Lung Cancer Research Studies (2 papers). B. Bandstra is often cited by papers focused on Lung Cancer Treatments and Mutations (5 papers), Colorectal Cancer Treatments and Studies (2 papers) and Lung Cancer Research Studies (2 papers). B. Bandstra collaborates with scholars based in United States, United Kingdom and Ireland. B. Bandstra's co-authors include Jack W. Singer, F. B. Oldham, Mary O’Brien, Amy J. Eisenfeld, Ronald J. Trancik, Madeleine Duvic, Vicente Valero, Sharon R. Hymes, Gabriel N. Hortobágyi and Linda D. Compton and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Journal of the American Academy of Dermatology.

In The Last Decade

B. Bandstra

7 papers receiving 354 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B. Bandstra United States 6 157 108 99 83 77 7 363
Ashish Bakshi India 11 127 0.8× 80 0.7× 69 0.7× 12 0.1× 7 0.1× 34 426
Song Yi Baek South Korea 9 51 0.3× 38 0.4× 80 0.8× 17 0.2× 7 0.1× 17 315
Kambiz Kamyab Hesari Iran 10 38 0.2× 57 0.5× 73 0.7× 92 1.1× 71 0.9× 30 327
Amir Zamani Iran 5 92 0.6× 62 0.6× 209 2.1× 22 0.3× 24 0.3× 7 483
Ilia Atanelishvili United States 9 20 0.1× 41 0.4× 90 0.9× 23 0.3× 17 0.2× 15 336
Francesco Molina Italy 10 78 0.5× 79 0.7× 208 2.1× 33 0.4× 21 0.3× 17 520
Piotr Zelga Poland 9 103 0.7× 54 0.5× 91 0.9× 21 0.3× 4 0.1× 29 324
Zhanxue Xu China 11 62 0.4× 33 0.3× 370 3.7× 19 0.2× 10 0.1× 21 560

Countries citing papers authored by B. Bandstra

Since Specialization
Citations

This map shows the geographic impact of B. Bandstra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Bandstra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Bandstra more than expected).

Fields of papers citing papers by B. Bandstra

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Bandstra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Bandstra. The network helps show where B. Bandstra may publish in the future.

Co-authorship network of co-authors of B. Bandstra

This figure shows the co-authorship network connecting the top 25 collaborators of B. Bandstra. A scholar is included among the top collaborators of B. Bandstra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. Bandstra. B. Bandstra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
2.
Paz‐Ares, Luis, Helen J. Ross, Mary O’Brien, et al.. (2008). Phase III trial comparing paclitaxel poliglumex vs docetaxel in the second-line treatment of non-small-cell lung cancer. British Journal of Cancer. 98(10). 1608–1613. 125 indexed citations
3.
Lilenbaum, Rogério, B. Bandstra, Corey J. Langer, et al.. (2007). B2-04: Single agent versus combination therapy in advanced NSCLC patients with performance status 2: Results from a regression analysis of STELLAR 3 and 4. Journal of Thoracic Oncology. 2(8). S337–S338. 2 indexed citations
4.
Ross, Helen J., F. B. Oldham, B. Bandstra, et al.. (2007). Serum-free estradiol (E2) levels are prognostic in men with chemotherapy-naive advanced non-small cell lung cancer (NSCLC) and performance status (PS) 2. Journal of Clinical Oncology. 25(18_suppl). 7683–7683. 15 indexed citations
5.
Bonomi, P., Christiane Langer, Kenneth J. O’Byrne, et al.. (2006). Analysis of prognostic factors in chemo-naïve patients with advanced NSCLC and poor performance status (PS): Cox regression analysis of two phase III trials. Journal of Clinical Oncology. 24(18_suppl). 7113–7113. 5 indexed citations
6.
Bonomi, Philip, Corey J. Langer, E O’Brien, et al.. (2006). Analysis of prognostic factors in patients with advanced relapsed/refractory NSCLC: Cox regression analysis of a randomized phase III trial comparing docetaxel and paclitaxel poliglumex (PPX). Journal of Clinical Oncology. 24(18_suppl). 7040–7040. 10 indexed citations
7.
Duvic, Madeleine, Noreen A. Lemak, Vicente Valero, et al.. (1996). A randomized trial of minoxidil in chemotherapy-induced alopecia. Journal of the American Academy of Dermatology. 35(1). 74–78. 110 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026